Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

3.375 -0.055 (-1.60%)
Streaming Delayed Price Updated: 11:33 AM EDT, Sep 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 Next >
Why Are Evotec Shares Trading Lower On Friday?
Bayer AG (OTC: BAYRY) has  
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,... 
Via Benzinga
From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances
Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Maravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating
One key metric to look for in a stock is 80-plus RS Rating. Maravai Lifesciences stock just hit that mark, with a jump from 71 to 81 Monday. 
Via Investor's Business Daily
Composite Rating For Regeneron Stock Rises To 96
Regeneron stock saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 93 the day before for the New York firm. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: 
Via Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses... 
Via Benzinga
Exposures COVID-19 Product Safety
EXCLUSIVE: This Company Hopes to Take an Innovative Approach To Treat Addiction
Photo by Myriam Zilles... 
Via Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.